Senior insider sale
EVP, Head of R&D at DIANTHUS THERAPEUTICS, INC. /DE/ — senior position signals high conviction
$2.44M
23.12K shares
What this filing means
RANDHAWA SIMRAT plans to sell 23.12K shares of DIANTHUS THERAPEUTICS, INC. /DE/ valued at approximately $2.44M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/1/2026ACC: 0001950047-26-008950
Officer· EVP, Head of R&D
Since Mar 2026
23.12K
Shares to sell
$2.44M
Approx. market value
23.12K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/1/2026
23.12KTotal acquired23.12K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/1/2026 | Exercise of Stock Options Cash | 23.12K | — |
| Total | 23.12K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
23.12K
Market value
$2.44M
9/1/2026
Total
Units
23.12K
Value
$2.44M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/1/2026 | 23.12K | $2.44M | NASDAQ | Planned |
| Total | 23.12K | $2.44M | ||